[Skip to Content]

Claim CME

Dermatology

Managing Facial Hyperpigmentation

To identify the key insights or developments described in this article

1 Credit CME

JAMA Dermatology

Published Online: June 7, 2023

JAMA Network Insights

Article Information and Disclosures

Roopal V. Kundu, MD¹;

Oyinade Aderibigbe, MD¹;

Julia M. Riley, MD¹

Author Affiliations

¹Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Read article on JAMA Network

Read Article Claim CME

Claim CME

Sign in to take quiz and track your certificates

Buy This Activity

Article Information

Corresponding Author: Roopal V. Kundu, MD, Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N St Clair St, Ste 1600, Chicago, IL 60611 (roopal.kundu@nm.org).

Published Online: June 7, 2023. doi:10.1001/jamadermatol.2023.1414

Conflict of Interest Disclosures: Dr Kundu reported personal fees (royalties) from UpToDate outside the submitted work. Dr Riley reported personal fees from Novartis Pharmaceuticals outside the submitted work. No other disclosures were reported.

References

Davis SA , Narahari S , Feldman SR , Huang W , Pichardo-Geisinger RO , McMichael AJ . Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol. 2012;11(4):466-473.PubMed Google Scholar

Maymone MBC , Neamah HH , Wirya SA , et al. The impact of skin hyperpigmentation and hyperchromia on quality of life: a cross-sectional study. J Am Acad Dermatol. 2017;77(4):775-778. doi:10.1016/j.jaad.2017.05.009 PubMed Google Scholar Crossref

Lyons AB , Trullas C , Kohli I , Hamzavi IH , Lim HW . Photoprotection beyond ultraviolet radiation: a review of tinted sunscreens. J Am Acad Dermatol. 2021;84(5):1393-1397. doi:10.1016/j.jaad.2020.04.079 PubMed Google Scholar Crossref

Mahmoud BH , Ruvolo E , Hexsel CL , et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol. 2010;130(8):2092-2097. doi:10.1038/jid.2010.95 PubMed Google Scholar Crossref

Tse TW . Hydroquinone for skin lightening: safety profile, duration of use and when should we stop? J Dermatolog Treat. 2010;21(5):272-275. doi:10.3109/09546630903341945 PubMed Google Scholar Crossref

Ferreira Cestari T , Hassun K , Sittart A , de Lourdes Viegas M . A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. J Cosmet Dermatol. 2007;6(1):36-39. doi:10.1111/j.1473-2165.2007.00288.x PubMed Google Scholar Crossref

Austin E , Nguyen JK , Jagdeo J . Topical treatments for melasma: a systematic review of randomized controlled trials. J Drugs Dermatol. 2019;18(11):S1545961619P1156X.PubMed Google Scholar

Kim KM , Lim HW . The uses of tranexamic acid in dermatology: a review. Int J Dermatol. 2023;62(5):589-598. doi:10.1111/ijd.16160 PubMed Google Scholar Crossref

Bailey AJM , Li HO , Tan MG , Cheng W , Dover JS . Microneedling as an adjuvant to topical therapies for melasma: a systematic review and meta-analysis. J Am Acad Dermatol. 2022;86(4):797-810. doi:10.1016/j.jaad.2021.03.116 PubMed Google Scholar Crossref

Lai D , Zhou S , Cheng S , Liu H , Cui Y . Laser therapy in the treatment of melasma: a systematic review and meta-analysis. Lasers Med Sci. 2022;37(4):2099-2110. doi:10.1007/s10103-022-03514-2 PubMed Google Scholar Crossref

AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
1.00 credit toward the CME [and Self-Assessment requirements] of the American Board of Surgery’s Continuous Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.